AVTX
Price
$16.07
Change
-$0.11 (-0.68%)
Updated
Jan 15, 11:07 AM (EDT)
Capitalization
300.28M
Intraday BUY SELL Signals
MGTX
Price
$7.53
Change
+$0.08 (+1.07%)
Updated
Jan 15, 11:48 AM (EDT)
Capitalization
600.46M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVTX vs MGTX

Header iconAVTX vs MGTX Comparison
Open Charts AVTX vs MGTXBanner chart's image
Avalo Therapeutics
Price$16.07
Change-$0.11 (-0.68%)
Volume$4.22K
Capitalization300.28M
MeiraGTx Holdings
Price$7.53
Change+$0.08 (+1.07%)
Volume$100
Capitalization600.46M
AVTX vs MGTX Comparison Chart in %
AVTX
Daily Signal:
Gain/Loss:
MGTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVTX vs. MGTX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and MGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AVTX: $16.19 vs. MGTX: $7.45)
Brand notoriety: AVTX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 169% vs. MGTX: 36%
Market capitalization -- AVTX: $300.28M vs. MGTX: $600.46M
AVTX [@Biotechnology] is valued at $300.28M. MGTX’s [@Biotechnology] market capitalization is $600.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 3 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • AVTX’s TA Score: 3 bullish, 6 bearish.
  • MGTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both AVTX and MGTX are a bad buy in the short-term.

Price Growth

AVTX (@Biotechnology) experienced а -4.43% price change this week, while MGTX (@Biotechnology) price change was -3.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

MGTX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($600M) has a higher market cap than AVTX($300M). MGTX YTD gains are higher at: -6.289 vs. AVTX (-10.848). AVTX has higher annual earnings (EBITDA): -66.1M vs. MGTX (-143.78M). AVTX has more cash in the bank: 112M vs. MGTX (14.8M). AVTX has less debt than MGTX: AVTX (555K) vs MGTX (88.1M). MGTX has higher revenues than AVTX: MGTX (27.4M) vs AVTX (192K).
AVTXMGTXAVTX / MGTX
Capitalization300M600M50%
EBITDA-66.1M-143.78M46%
Gain YTD-10.848-6.289172%
P/E Ratio2.30N/A-
Revenue192K27.4M1%
Total Cash112M14.8M757%
Total Debt555K88.1M1%
FUNDAMENTALS RATINGS
AVTX vs MGTX: Fundamental Ratings
AVTX
MGTX
OUTLOOK RATING
1..100
5464
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3663
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
1950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (86) in the Pharmaceuticals Other industry is in the same range as MGTX (94) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MGTX’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MGTX (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MGTX’s over the last 12 months.

AVTX's SMR Rating (99) in the Pharmaceuticals Other industry is in the same range as MGTX (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MGTX’s over the last 12 months.

AVTX's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as MGTX (63) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MGTX’s over the last 12 months.

AVTX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for MGTX (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXMGTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signal:
Gain/Loss:
MGTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GUROF4.600.33
+7.78%
Guru Organic Energy Co.
MIELY64.380.86
+1.35%
Mitsubishi Electric Corp.
CPBLF13.47N/A
N/A
ALS Ltd.
IZOZF0.21N/A
N/A
Izotropic Corporation
FHNGY4.97N/A
N/A
Foschini Group Ltd. (The)

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with MEOBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then MEOBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-5.87%
MEOBF - AVTX
46%
Loosely correlated
-16.32%
PGEN - AVTX
34%
Loosely correlated
+5.76%
MGTX - AVTX
33%
Loosely correlated
+0.95%
TARA - AVTX
33%
Poorly correlated
+0.41%
BDRX - AVTX
32%
Poorly correlated
-8.73%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+0.95%
IDYA - MGTX
48%
Loosely correlated
+5.53%
XENE - MGTX
46%
Loosely correlated
+3.02%
AURA - MGTX
45%
Loosely correlated
+3.95%
RGNX - MGTX
45%
Loosely correlated
-0.66%
NUVL - MGTX
44%
Loosely correlated
+6.59%
More